Keyphrases
Resistance Mechanisms
100%
Gastrointestinal Stromal Tumor
100%
Imatinib
100%
Resistance to Imatinib
100%
Sunitinib
100%
Exon 11
50%
Binding Affinity
50%
FDA-approved Drugs
25%
Tumor
25%
Sarcoma
25%
Resistant Disease
25%
High Dose
25%
Gene mutation
25%
Gastrointestinal Tract
25%
Codon
25%
Exon 9
25%
Platelet-derived Growth Factor Receptor (PDGFR)
25%
Unique mutation
25%
KIT mutation
25%
Mesenchymal Neoplasm
25%
Imatinib Mesylate
25%
KIT Inhibitors
25%
Sunitinib Malate
25%
Imatinib Resistance
25%
ATP-binding Pocket
25%
KIT Signaling
25%
Biochemistry, Genetics and Molecular Biology
Sunitinib
100%
Imatinib
100%
Exon
42%
Binding Affinity
28%
Adenosine Triphosphate
14%
Phosphotransferase
14%
Kinase
14%
Gene Mutation
14%
Drug Megadose
14%
Codon
14%
Platelet-Derived Growth Factor Receptor
14%